Bioconcepts Mastering Pathology Summit. 25-26 Oct 2024 with Dr Janet Schloss

In today's episode the focus shifts to an engaging conversation with Dr. Janet Schloss, a leading figure in naturopathy and clinical research in oncology. The dialogue unveils the breadth of Dr. Schloss’s professional journey, highlighting her contributions to cancer care and evidence-backed complementary medicine. As they talk, Dr. Schloss shares insights about her extensive career involving research and teaching roles, her PhD work on B vitamins’ role in chemotherapy-induced peripheral neuropathy, and her ongoing impactful clinical trials at Southern Cross University, NSW.

Listeners will also get the lowdown on the Bioconcepts Mastering Pathology Summit, to be held on 25-26th October 2024, where Dr. Schloss will present alongside a star-studded lineup of speakers on critical clinic-relevent topics. The event promises to enrich practitioners’ understanding of pathology, explaining the significance of different cancer tests and how such knowledge can be applied in clinical settings. By attending this summit, participants can expect to gain valuable insights to elevate their practice and provide superior patient care, reinforcing the theme of practitioner knowledge directly benefitting patient outcomes.

Get Your Virtual Tickets Now
https://info.bioconcepts.com.au/pathology-summit/pricing?hsCtaTracking=21d48747-d35c-4e36-9015-b3f4af0b48cc%7C70f6b9a1-f874-47ca-9d96-ea59dc52807c#pricing

Transcript

Timestamp Summary
| 0:00  | Introduction and Disclaimer
| 0:44  | Welcome Dr. Janet Schloss
| 1:17  | Dr. Schloss's Career Journey
| 2:44  | PhD and Research Focus
| 3:18  | Current Role at Southern Cross University
| 4:04  | Acknowledgment of Henry Osecki
| 4:57  | Henry Osecki's Contributions
| 5:12  | Legacy Continued by Michael Osecki
| 5:50  | Upcoming Event: Mastering Pathology Summit 2024
| 6:27  | Focus on Cancer Pathology
| 7:04  | Fine Needle vs. Core Biopsy
| 8:01  | Event Importance for Clinicians
| 8:45  | Patient-Centered Care
| 9:14  | Closing Remarks and Event Details

0:00:09 - (Andrew Whitfield-Cook): Welcome to the Natural Medicine podcast.

0:00:11 - (Andrew Whitfield-Cook): I'm your host, Andrew Whitfield Cook.

0:00:14 - (Andrew Whitfield-Cook): Join us as we interview expert clinicians, researchers, and wellbeing experts from around the world and explore the evidence and application of complementary medicine in global healthcare. The following podcast is intended as professional information for integrated practitioners and as such, not be taken as medical advice. Patients are expressly directed to seek appropriate care from a suitably qualified practitioner.

0:00:44 - (Andrew Whitfield-Cook): Hi everyone. Welcome back to the Natural Medicine podcast. Today we're speaking with doctor Janet Schloss. We've got some exciting news about an upcoming event in October 2024. Janet, how are you?

0:00:56 - (Dr Janet Schloss): I'm really good, Andrew. So good to see you again.

0:00:58 - (Andrew Whitfield-Cook): It's so good to see you. It's been a while, hasn't it, since we've had a chat. Now, for those very few people who may not know you, can you take us through just a brief history of your career, please? Because it's quite extensive, changed tack a few times and it sort of leads into what we're really discussing today.

0:01:17 - (Dr Janet Schloss): Yeah, definitely. So I'm a naturopath and nutritionist now for, I think, 25 or so years. In the first couple of years when I graduated, I started work with bioconcepts. So just three days a week I was helping Henry or Seki write books, do research, help with seminars and all that type of stuff. And I did that for about three or four years. And I think that's when I first met you.

0:01:46 - (Andrew Whitfield-Cook): Yes, it is.

0:01:47 - (Dr Janet Schloss): With the cancer biochemistry book, which is.

0:01:52 - (Andrew Whitfield-Cook): Good in a cafe at South Brisbane. I'll always remember it, always remember it.

0:01:56 - (Dr Janet Schloss): That was good from there. When I left bioconcepts, I was working and teaching at Endeavour. I went and did my postgrad in clinical nutrition and still was teaching and stuff and then decided to actually have a baby, which was, you know, always a bonus. And then did my ph when she was like about 1516 months. I did my PhD at the School of Medicine at UQ and looking at B vitamins for chemotherapy induced peripheral neuropathy and bioconcepts actually sponsored me for that with a scholarship as well as provided all the supplements and stuff for the trial and Sibo, which was just fantastic.

0:02:44 - (Dr Janet Schloss): So from there, I then went into the world of research. Once I don't like running clinical research, I went to endeavor office of Research there, where we ran quite a number of different trials. Probably the biggest one was my medicinal cannabis and brain tumor TBM trial and tear. After Endeavour decided to close its office of research, I went to Southern Cross University. So the National center for Naturopathic Medicine, where I work as a clinical research fellow. Still, I've been there now for over five years. Oh, no, four years. Sorry.

0:03:18 - (Dr Janet Schloss): And we've got a fantastic clinical research team where we run clinical trials and stuff like that. Obviously, NCNM and SU also have all the courses and stuff for naturopaths and stuff, but most of it, I'm actually in the research and I'm still conducting lots of different trial. So that's a very quick snippet. Amongst, like, the 70 odd papers that I've written, I don't know how many book chapters, blah, blah, blah.

0:03:43 - (Andrew Whitfield-Cook): That's right. Now we have to also give a call out. You mentioned Henry Oseeki, the founder of bioconcepts and orthoplex, and a lot of people don't realize just how far back Henry goes and what we have to thank him for. He was the first person to bring glucosamine to Australia. He was the first person to bring coq ten to Australia when we were restricted to a whole ten milligrams. There's a number of groundbreaking products which he's brought to market. Alpha ketoglutarate, lipoic acid was his.

0:04:19 - (Andrew Whitfield-Cook): He was the first person to bring lipoic acid into Australia. It goes on and on and people don't really receive the accolades because he's always kept out of the limelight. Even to the point of your research trial. He provided not just yours, but other raw materials and funding for research trials, but he never publicised it. People just don't know, really how important this man has been to the furthering of not just careers for clinicians, but also the evidence for natural medicines in modern healthcare.

0:04:57 - (Dr Janet Schloss): Absolutely. And one of the things we have talked about previously, you know, he's one of the grandfathers of naturopathy and the products and stuff like that, and totally agree with you. And we're so lucky now that his son's actually carrying on the legacy.

0:05:12 - (Andrew Whitfield-Cook): Absolutely. And not. Not just a commercial legacy like this man. He's smart, like, he's really smart, but he's also got heart. And this is one thing that, you know, I really give accolades to Michael in that he can't be bought if it's got the evidence yet. If it stacks up, we'll go with it. If it won't, he says, no, not yet. I really admire him for that. And so let's discuss a little bit about what you're going to be involved in later on this year. So I think it's October 25 26th, 2024. So this is the mastering pathology summit.

0:05:50 - (Andrew Whitfield-Cook): Take us through a little bit about what you'll be talking about and how it's going to help clinicians in their day to day practice.

0:05:57 - (Dr Janet Schloss): Yeah. So one of the things I didn't say before, probably, is that my main area that I've been working in for a really long time is cancer, in particular cancer oncology. Like, I did my research, my PhD at the PA hospital on the oncology floor with all the oncologists. So I've been working with a lot of the medical oncologists, radiation surgeons for quite a long time, and I've been working with patients now for over 20 years with cancer.

0:06:27 - (Dr Janet Schloss): So the talk that I'm going to be doing is cancer pathology, and it's not just our normal type thing. Yes. I'll be going through, like, some of the different types of biopsies, why they actually do different things, how they can read, like, some of the reports. I'll be talking about some of the general bloods that get done and how they can actually use that to be able to monitor how that their patient is actually going, not just with, say, the traditional ones, but also just some of the treatments that they're actually giving.

0:06:54 - (Dr Janet Schloss): And then I'll also talk about some of the other testing, like circulating tumor cells. So CTCs and other things that we have the option of being able to use.

0:07:04 - (Andrew Whitfield-Cook): Gotcha. Well, you mentioned biopsies before, so let's go through that, because I have to tag you on something. And that is something that's perplexed me. Women offering suffering, who I've seen suffering from breast cancer, and they've had a fine needle biopsy or aspiration, which then always progresses to a core biopsy. What's the point, then, of doing the fine needle if they're always going to do the core biopsy?

0:07:31 - (Dr Janet Schloss): The fine needle is less invasive than a core, and what they're wanting to do is make sure that it is actually cancerous, not benign, that they're actually looking at now. So if it's benign, they don't go on to do a core biopsy. However, if it is shown cancerous, then they go to a core biopsy because they get more information and it's more invasive, like I said.

0:07:51 - (Andrew Whitfield-Cook): Well, there's something I've learned straight away. Thank you so much. It's a biased sample that I'm seeing. I'm seeing those people that are coming to seek help for breast cancer.

0:08:01 - (Dr Janet Schloss): Right. So they've actually had to go on and get the further testing done.

0:08:05 - (Andrew Whitfield-Cook): Gotcha. Gotcha. Thank you so much for clearing that one up. And I gather you'll clear up so many more during your talk. And of course there's so many more experts that we're going to be hearing from at this talk. So we're going to be learning a heck of a lot, not just in one stream, but in all different sort of facets of clinical life, so that we can take them back and help patients. That to me is the core. It's got to be for the patient's benefit.

0:08:28 - (Dr Janet Schloss): Absolutely. Always has to be for the patient's benefit. The whole idea is, should be patient centered, so we should be able to learn this type, but be then be able to implement it and a translation into practice so that people can actually help the people that sitting right in front of them, because that's the most important thing.

0:08:45 - (Andrew Whitfield-Cook): So everyone. 25th, 26 October. It's the mastering Pathology Summit 2024 by bioconcepts, connecting patterns with presentation. It's a vital event that you have to be there to learn so much more. Doctor Janet Schloss, I thank you very much, not just for your clinical expertise, but your heart. I know you well and I know what you're about. So thank you for all of your work that you've done for your patients throughout the years.

0:09:14 - (Dr Janet Schloss): Thank you so much, Andrew. It's always a pleasure and lovely speaking to you.

0:09:17 - (Andrew Whitfield-Cook): Now, remember, you can catch up on all the other podcasts in the show notes where you can click on it and secure your spot. See you in October.